| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 54 | 2024 | 2655 | 3.250 |
Why?
|
| Radiography, Abdominal | 4 | 2024 | 69 | 1.300 |
Why?
|
| Earthquakes | 2 | 2023 | 12 | 1.120 |
Why?
|
| Emergencies | 3 | 2024 | 121 | 0.950 |
Why?
|
| Radiology Information Systems | 1 | 2024 | 78 | 0.910 |
Why?
|
| Rib Fractures | 1 | 2023 | 8 | 0.900 |
Why?
|
| Disasters | 1 | 2023 | 21 | 0.890 |
Why?
|
| Ribs | 1 | 2023 | 46 | 0.880 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2022 | 3 | 0.830 |
Why?
|
| Contrast Media | 10 | 2019 | 1090 | 0.810 |
Why?
|
| Chylous Ascites | 2 | 2011 | 9 | 0.730 |
Why?
|
| Cerebral Angiography | 7 | 2015 | 197 | 0.730 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2017 | 237 | 0.720 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2015 | 38 | 0.680 |
Why?
|
| Embolism, Air | 2 | 2017 | 23 | 0.660 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 20 | 0.620 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 478 | 0.610 |
Why?
|
| Diagnosis, Differential | 16 | 2016 | 1590 | 0.610 |
Why?
|
| Necrosis | 2 | 2023 | 209 | 0.610 |
Why?
|
| Thrombolytic Therapy | 4 | 2015 | 232 | 0.610 |
Why?
|
| Thrombosis | 3 | 2017 | 302 | 0.580 |
Why?
|
| Cerebrum | 1 | 2017 | 16 | 0.580 |
Why?
|
| Splenic Artery | 1 | 2017 | 11 | 0.580 |
Why?
|
| Pancreatitis | 1 | 2017 | 86 | 0.580 |
Why?
|
| Humans | 80 | 2024 | 88875 | 0.580 |
Why?
|
| Thoracic Vertebrae | 3 | 2017 | 51 | 0.580 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 79 | 0.550 |
Why?
|
| Stroke | 5 | 2022 | 979 | 0.550 |
Why?
|
| Liver Diseases | 4 | 2017 | 242 | 0.510 |
Why?
|
| Stents | 3 | 2007 | 395 | 0.500 |
Why?
|
| Middle Aged | 37 | 2024 | 25787 | 0.500 |
Why?
|
| Female | 48 | 2024 | 45912 | 0.480 |
Why?
|
| Drainage | 3 | 2011 | 161 | 0.470 |
Why?
|
| Brain Ischemia | 5 | 2022 | 399 | 0.470 |
Why?
|
| Aged | 28 | 2024 | 19019 | 0.460 |
Why?
|
| Retroperitoneal Space | 2 | 2017 | 38 | 0.460 |
Why?
|
| Abdomen | 2 | 2017 | 122 | 0.450 |
Why?
|
| Thoracic Cavity | 1 | 2013 | 2 | 0.450 |
Why?
|
| Intracranial Embolism | 3 | 2017 | 29 | 0.440 |
Why?
|
| Male | 46 | 2024 | 42147 | 0.440 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2011 | 11 | 0.440 |
Why?
|
| Myositis | 1 | 2013 | 18 | 0.440 |
Why?
|
| Meglumine | 2 | 2011 | 38 | 0.440 |
Why?
|
| Aspergillosis | 1 | 2013 | 41 | 0.430 |
Why?
|
| Lipomatosis | 1 | 2012 | 9 | 0.430 |
Why?
|
| Hepatolenticular Degeneration | 3 | 2007 | 19 | 0.410 |
Why?
|
| Abdominal Pain | 6 | 2017 | 138 | 0.410 |
Why?
|
| Organometallic Compounds | 2 | 2011 | 134 | 0.410 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 98 | 0.390 |
Why?
|
| Hematoma | 2 | 2011 | 108 | 0.390 |
Why?
|
| Foreign Bodies | 2 | 2013 | 66 | 0.390 |
Why?
|
| Lung | 4 | 2021 | 1257 | 0.380 |
Why?
|
| Carcinoma | 3 | 2011 | 442 | 0.380 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2011 | 81 | 0.380 |
Why?
|
| Adult | 30 | 2024 | 26440 | 0.370 |
Why?
|
| Nuclear Medicine | 1 | 2010 | 12 | 0.370 |
Why?
|
| Cholecystitis, Acute | 2 | 2010 | 8 | 0.370 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2011 | 302 | 0.360 |
Why?
|
| Liver | 4 | 2017 | 1204 | 0.360 |
Why?
|
| Neck Injuries | 1 | 2010 | 13 | 0.360 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 18 | 0.350 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 56 | 0.350 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 6758 | 0.340 |
Why?
|
| Publishing | 1 | 2010 | 90 | 0.340 |
Why?
|
| Sensitivity and Specificity | 8 | 2021 | 2013 | 0.330 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 110 | 0.330 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 2751 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2991 | 0.320 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 168 | 0.310 |
Why?
|
| Urologic Diseases | 1 | 2008 | 44 | 0.310 |
Why?
|
| Head Injuries, Closed | 1 | 2007 | 12 | 0.300 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2007 | 8 | 0.300 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2007 | 15 | 0.300 |
Why?
|
| Lumbar Vertebrae | 2 | 2009 | 151 | 0.290 |
Why?
|
| Appendicitis | 2 | 2019 | 64 | 0.290 |
Why?
|
| Ileal Diseases | 1 | 2007 | 26 | 0.290 |
Why?
|
| Observer Variation | 3 | 2023 | 610 | 0.290 |
Why?
|
| Arteries | 1 | 2008 | 180 | 0.290 |
Why?
|
| Abdominal Injuries | 1 | 2007 | 46 | 0.290 |
Why?
|
| Thoracic Injuries | 1 | 2007 | 38 | 0.290 |
Why?
|
| Embolization, Therapeutic | 3 | 2010 | 262 | 0.290 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2007 | 108 | 0.280 |
Why?
|
| Fibrinolytic Agents | 3 | 2015 | 214 | 0.270 |
Why?
|
| Hemorrhage | 1 | 2008 | 278 | 0.270 |
Why?
|
| Adolescent | 15 | 2021 | 9214 | 0.270 |
Why?
|
| Gallbladder | 3 | 2011 | 31 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2020 | 685 | 0.270 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 181 | 0.270 |
Why?
|
| Ureteral Diseases | 1 | 2005 | 14 | 0.260 |
Why?
|
| Scrotum | 1 | 2005 | 17 | 0.260 |
Why?
|
| Ultrasonography | 7 | 2013 | 710 | 0.260 |
Why?
|
| Pulmonary Embolism | 2 | 2020 | 228 | 0.260 |
Why?
|
| Carotid Artery, Internal | 3 | 2015 | 68 | 0.260 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 96 | 0.250 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 1835 | 0.250 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 754 | 0.250 |
Why?
|
| Retrospective Studies | 15 | 2021 | 8973 | 0.250 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 226 | 0.240 |
Why?
|
| Child | 13 | 2019 | 7133 | 0.240 |
Why?
|
| Portal Vein | 3 | 2017 | 120 | 0.240 |
Why?
|
| Hernia, Inguinal | 1 | 2005 | 73 | 0.240 |
Why?
|
| Ureter | 1 | 2005 | 93 | 0.240 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2004 | 8 | 0.240 |
Why?
|
| Arachnoid Cysts | 1 | 2004 | 2 | 0.240 |
Why?
|
| Radiography | 7 | 2013 | 809 | 0.240 |
Why?
|
| Acute Disease | 5 | 2019 | 838 | 0.240 |
Why?
|
| Cerebral Hemorrhage | 3 | 2011 | 338 | 0.230 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2004 | 25 | 0.230 |
Why?
|
| Crush Syndrome | 1 | 2023 | 1 | 0.230 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 65 | 0.230 |
Why?
|
| Meningioma | 1 | 2004 | 63 | 0.230 |
Why?
|
| Young Adult | 10 | 2021 | 6271 | 0.220 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 351 | 0.220 |
Why?
|
| Radiologists | 1 | 2023 | 45 | 0.220 |
Why?
|
| Splenic Infarction | 1 | 2002 | 2 | 0.220 |
Why?
|
| Salmonella enterica | 1 | 2002 | 8 | 0.220 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 102 | 0.220 |
Why?
|
| Salmonella Infections | 1 | 2002 | 18 | 0.210 |
Why?
|
| Brain Diseases | 1 | 2004 | 185 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2024 | 4259 | 0.210 |
Why?
|
| Triage | 1 | 2023 | 111 | 0.210 |
Why?
|
| Calcinosis | 1 | 2004 | 230 | 0.210 |
Why?
|
| Emergency Service, Hospital | 3 | 2013 | 520 | 0.210 |
Why?
|
| Patient Admission | 2 | 2013 | 114 | 0.200 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 1713 | 0.200 |
Why?
|
| Angiography | 3 | 2015 | 208 | 0.190 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2021 | 468 | 0.190 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 119 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 182 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2015 | 168 | 0.180 |
Why?
|
| Thorax | 1 | 2020 | 77 | 0.180 |
Why?
|
| Kidney | 2 | 2020 | 1145 | 0.180 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 589 | 0.180 |
Why?
|
| Risk Factors | 8 | 2022 | 5453 | 0.170 |
Why?
|
| Area Under Curve | 2 | 2017 | 337 | 0.170 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 18 | 0.170 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 144 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 783 | 0.160 |
Why?
|
| Sternum | 1 | 2019 | 34 | 0.160 |
Why?
|
| Software | 1 | 2023 | 665 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 320 | 0.160 |
Why?
|
| Urinary Calculi | 2 | 2009 | 46 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 159 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2019 | 3704 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2010 | 595 | 0.140 |
Why?
|
| Fasciitis | 1 | 2017 | 10 | 0.140 |
Why?
|
| Osteogenesis | 1 | 2019 | 255 | 0.140 |
Why?
|
| Coronary Angiography | 2 | 2009 | 239 | 0.140 |
Why?
|
| Kyphosis | 1 | 2016 | 14 | 0.140 |
Why?
|
| Klebsiella Infections | 1 | 2017 | 27 | 0.140 |
Why?
|
| Scoliosis | 1 | 2016 | 32 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 150 | 0.140 |
Why?
|
| Dyspnea | 1 | 2017 | 75 | 0.140 |
Why?
|
| Pancreas | 1 | 2017 | 244 | 0.130 |
Why?
|
| Carotid Stenosis | 2 | 2009 | 115 | 0.130 |
Why?
|
| Disease Progression | 2 | 2017 | 1483 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.130 |
Why?
|
| Rheumatic Diseases | 1 | 2015 | 26 | 0.120 |
Why?
|
| Radiation Dosage | 3 | 2020 | 225 | 0.120 |
Why?
|
| Vascular Calcification | 1 | 2015 | 51 | 0.120 |
Why?
|
| Colitis | 1 | 2017 | 244 | 0.110 |
Why?
|
| Syndrome | 2 | 2012 | 449 | 0.110 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 35 | 0.110 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Meninges | 1 | 2013 | 14 | 0.110 |
Why?
|
| Deglutition | 1 | 2013 | 76 | 0.110 |
Why?
|
| Collateral Circulation | 1 | 2013 | 35 | 0.110 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 360 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2018 | 778 | 0.100 |
Why?
|
| Treatment Outcome | 6 | 2017 | 8178 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2013 | 119 | 0.100 |
Why?
|
| Prognosis | 3 | 2015 | 3757 | 0.100 |
Why?
|
| Adrenalectomy | 1 | 2011 | 45 | 0.100 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2009 | 99 | 0.100 |
Why?
|
| Glasgow Coma Scale | 2 | 2011 | 73 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 227 | 0.100 |
Why?
|
| Papilloma | 1 | 2011 | 22 | 0.100 |
Why?
|
| Bile Ducts | 1 | 2011 | 59 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 2 | 2021 | 270 | 0.090 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 36 | 0.090 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2011 | 33 | 0.090 |
Why?
|
| Turkey | 1 | 2010 | 21 | 0.090 |
Why?
|
| Bronchial Arteries | 1 | 2010 | 3 | 0.090 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2010 | 2 | 0.090 |
Why?
|
| Echinococcosis | 1 | 2010 | 5 | 0.090 |
Why?
|
| Hemoptysis | 1 | 2010 | 24 | 0.090 |
Why?
|
| Resuscitation Orders | 1 | 2011 | 63 | 0.090 |
Why?
|
| Gallstones | 1 | 2010 | 15 | 0.090 |
Why?
|
| Choledocholithiasis | 1 | 2010 | 13 | 0.090 |
Why?
|
| Water Intoxication | 1 | 2010 | 3 | 0.090 |
Why?
|
| Science | 1 | 2010 | 34 | 0.090 |
Why?
|
| Bile | 1 | 2010 | 57 | 0.090 |
Why?
|
| Flank Pain | 2 | 2009 | 5 | 0.090 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 41 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2011 | 143 | 0.090 |
Why?
|
| Internal Fixators | 1 | 2009 | 14 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 159 | 0.090 |
Why?
|
| Pelvis | 1 | 2010 | 96 | 0.090 |
Why?
|
| Pelvic Bones | 1 | 2009 | 43 | 0.080 |
Why?
|
| Iohexol | 1 | 2009 | 25 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2011 | 299 | 0.080 |
Why?
|
| Fracture Fixation, Internal | 1 | 2009 | 65 | 0.080 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2009 | 3 | 0.080 |
Why?
|
| Jejunal Diseases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Dysmenorrhea | 1 | 2010 | 53 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2009 | 567 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2012 | 3442 | 0.080 |
Why?
|
| Mesentery | 1 | 2008 | 45 | 0.080 |
Why?
|
| Laparotomy | 1 | 2008 | 67 | 0.080 |
Why?
|
| Hemothorax | 1 | 2008 | 15 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 713 | 0.080 |
Why?
|
| Hypertension | 2 | 2011 | 741 | 0.080 |
Why?
|
| Cystitis | 1 | 2008 | 14 | 0.080 |
Why?
|
| Pneumocephalus | 1 | 2008 | 10 | 0.080 |
Why?
|
| Osteoradionecrosis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Myocardial Bridging | 1 | 2007 | 3 | 0.080 |
Why?
|
| Iopamidol | 1 | 2007 | 10 | 0.080 |
Why?
|
| Ileum | 1 | 2008 | 160 | 0.070 |
Why?
|
| Aortic Rupture | 1 | 2008 | 57 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 400 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 44 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2008 | 47 | 0.070 |
Why?
|
| Anisotropy | 1 | 2007 | 63 | 0.070 |
Why?
|
| Jejunum | 1 | 2007 | 80 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 898 | 0.070 |
Why?
|
| Aneurysm | 1 | 2007 | 60 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2009 | 158 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 306 | 0.070 |
Why?
|
| Cysts | 1 | 2008 | 106 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 510 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 89 | 0.070 |
Why?
|
| Algorithms | 2 | 2017 | 1870 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2008 | 184 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2022 | 2286 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 169 | 0.070 |
Why?
|
| Ischemia | 1 | 2008 | 250 | 0.070 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 141 | 0.070 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2006 | 3 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2006 | 19 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2007 | 253 | 0.070 |
Why?
|
| Ureteroscopy | 1 | 2005 | 38 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2005 | 64 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 50 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2008 | 335 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 987 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2012 | 3649 | 0.060 |
Why?
|
| Venous Insufficiency | 1 | 2004 | 12 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2004 | 30 | 0.060 |
Why?
|
| Stainless Steel | 1 | 2004 | 4 | 0.060 |
Why?
|
| Mandibular Condyle | 1 | 2004 | 7 | 0.060 |
Why?
|
| Brain | 2 | 2012 | 2269 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2004 | 30 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 74 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 112 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2008 | 394 | 0.060 |
Why?
|
| Logistic Models | 3 | 2013 | 1211 | 0.060 |
Why?
|
| Length of Stay | 1 | 2007 | 733 | 0.060 |
Why?
|
| Hypovolemia | 1 | 2023 | 3 | 0.060 |
Why?
|
| Infant | 3 | 2017 | 3138 | 0.060 |
Why?
|
| O Antigens | 1 | 2002 | 12 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2002 | 29 | 0.050 |
Why?
|
| Nausea | 2 | 2017 | 176 | 0.050 |
Why?
|
| Vomiting | 2 | 2017 | 194 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2002 | 91 | 0.050 |
Why?
|
| Time | 1 | 2021 | 76 | 0.050 |
Why?
|
| Kidney Pelvis | 1 | 2002 | 51 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 1862 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 1699 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 1354 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2002 | 67 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2469 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 29 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2013 | 684 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 221 | 0.040 |
Why?
|
| Pregnancy | 1 | 2007 | 3003 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 234 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 24 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 1233 | 0.040 |
Why?
|
| Radiography, Interventional | 2 | 2010 | 154 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.040 |
Why?
|
| Fecal Impaction | 1 | 2017 | 3 | 0.040 |
Why?
|
| Hepatic Veins | 1 | 2017 | 26 | 0.040 |
Why?
|
| Body Size | 1 | 2017 | 91 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 144 | 0.040 |
Why?
|
| Appendix | 1 | 2017 | 31 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2550 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 244 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2017 | 84 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 463 | 0.030 |
Why?
|
| Pressure | 1 | 2017 | 165 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 109 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 111 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 217 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 3020 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1062 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1796 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 166 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 430 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5313 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 509 | 0.030 |
Why?
|
| Alberta | 1 | 2012 | 8 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2013 | 140 | 0.030 |
Why?
|
| Leukoaraiosis | 1 | 2011 | 3 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2013 | 292 | 0.030 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2011 | 5 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2011 | 39 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cystic Duct | 1 | 2011 | 5 | 0.020 |
Why?
|
| Hepatic Duct, Common | 1 | 2011 | 10 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2011 | 64 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 66 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 779 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 80 | 0.020 |
Why?
|
| Cholecystography | 1 | 2010 | 6 | 0.020 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2010 | 11 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 72 | 0.020 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2011 | 83 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 421 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 70 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2009 | 29 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2009 | 33 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 44 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 122 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 185 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 77 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 43 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 240 | 0.020 |
Why?
|
| Embolism | 1 | 2009 | 32 | 0.020 |
Why?
|
| Enteritis | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 447 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 409 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 434 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 171 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 200 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 85 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 60 | 0.020 |
Why?
|
| Ureteral Calculi | 1 | 2006 | 10 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1011 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2009 | 298 | 0.020 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2004 | 1 | 0.020 |
Why?
|
| Phlebography | 1 | 2004 | 66 | 0.020 |
Why?
|
| Facial Pain | 1 | 2004 | 11 | 0.020 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2004 | 21 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2004 | 126 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 413 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 1881 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1591 | 0.010 |
Why?
|
| Registries | 1 | 2008 | 776 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 295 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 2006 | 341 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1989 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 2002 | 32 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2002 | 123 | 0.010 |
Why?
|
| Rotation | 1 | 2002 | 91 | 0.010 |
Why?
|